Navigation Links
NHP Reports 2009 Second Quarter Results
Date:8/5/2009

NEWPORT BEACH, Calif., Aug. 5 /PRNewswire-FirstCall/ -- Nationwide Health Properties, Inc. (NYSE: NHP) today announced results of operations for the second quarter and six months ended June 30, 2009. Contemporaneously with this press release, the Company filed its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2009 with the Securities and Exchange Commission.

"NHP's strong balance sheet is anchored by low leverage, ample liquidity and modest capital commitments through June 2011. Always looking to improve our balance sheet in this economic environment, to date we raised $105 million of equity and retired $30 million of our senior notes. On an enterprise value basis, our leverage is 35% and after our recent equity issuances we have about $199 million of cash as well as the full capacity of our $700 million credit facility," commented Douglas M. Pasquale, NHP's Chairman and Chief Executive Officer. "NHP is well positioned to take advantage of investment opportunities as they arise. We expect assets will begin to become available at attractive prices and we are prepared to make excellent investments as these opportunities present themselves," Mr. Pasquale added.

SECOND QUARTER 2009 RESULTS OF OPERATIONS

The following table presents selected unaudited financial information for the second quarter and the six months ended June 30, 2009 as compared to the same period of 2008:

                             SELECTED FINANCIAL DATA
                   ($ in thousands, except per share amounts)


                                            Three Months Ended June 30,
                                            ---------------------------
                                          2009     2008  $ Change  % Change
                                          ----     ----  --------  --------

    Revenue                            $97,311  $93,071    $4,240       4.6%
    Income from Continuing Operations  $34,809  $26,518    $8,291      31.3%
    Net Income Attributable to NHP
     Common Stockholders               $33,299 $165,951 $(132,652)    -79.9%
    Net Income Attributable to NHP
     Common Stockholders
     Per Diluted Share                   $0.31    $1.69    $(1.38)    -81.7%
    Diluted FFO                        $66,630  $57,806    $8,824      15.3%
    Recurring Diluted FFO              $62,066  $57,806    $4,260       7.4%
    Diluted FFO Per Share                $0.61    $0.56     $0.05       8.9%
    Recurring Diluted FFO Per Share      $0.57    $0.56     $0.01       1.8%
    Diluted FAD                        $66,242  $56,090   $10,152      18.1%
    Recurring Diluted FAD              $61,678  $56,090    $5,588      10.0%
    Diluted FAD Per Share                $0.61    $0.55     $0.06      10.9%
    Recurring Diluted FAD Per Share      $0.57    $0.55     $0.02       3.6%

                                             Six Months Ended June 30,
                                             -------------------------
                                          2009     2008  $ Change  % Change
                                          ----     ----  --------  --------

    Revenue                           $194,562 $178,342   $16,220       9.1%
    Income from Continuing Operations  $64,209  $49,461   $14,748      29.8%
    Net Income Attributable to NHP
     Common Stockholders               $82,453 $201,344 $(118,891)    -59.0%
    Net Income Attributable to NHP
     Common Stockholders
     Per Diluted Share                   $0.78    $2.07    $(1.29)    -62.3%
    Diluted FFO                       $128,197 $114,099   $14,098      12.4%
    Recurring Diluted FFO             $123,633 $114,099    $9,534       8.4%
    Diluted FFO Per Share                $1.18    $1.12     $0.06       5.4%
    Recurring Diluted FFO Per Share      $1.14    $1.12     $0.02       1.8%
    Diluted FAD                       $127,668 $110,661   $17,007      15.4%
    Recurring Diluted FAD             $123,104 $110,661   $12,443      11.2%
    Diluted FAD Per Share                $1.18    $1.09     $0.09       8.3%
    Recurring Diluted FAD Per Share      $1.14    $1.09     $0.05       4.6%

NON-GAAP FINANCIAL MEASURES

Diluted Funds From Operations ("FFO") and Diluted Funds Available for Distribution ("FAD") are non-GAAP measures that we believe are important to understanding our operations. We believe diluted FFO is an important supplemental measure of operating performance because it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). We believe diluted FAD is an important supplemental measure of operating performance because, like diluted FFO, it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). It also excludes straight-lined rent and other non-cash items that have become more significant for us and our competitors over the last several years. We believe that net income is the most directly comparable GAAP measure to diluted FFO and diluted FAD. Reconciliations between net income and diluted FFO and net income and diluted FAD are included in the accompanying financial data. For guidance, we have also included in the accompanying financial data reconciliations between net income per share and diluted FFO and diluted FAD per share. We have also included recurring diluted FFO and recurring diluted FAD amounts which exclude the recognition of a gain on debt extinguishment in 2009.

SECOND QUARTER 2009 INVESTMENT ACTIVITY

During the second quarter of 2009, we invested $6.0 million in revenue producing capital expenditures at a blended yield of 8.5% on our existing triple net portfolio.

In July 2009, we reached an agreement with The Broe Group to acquire all of their interests in two of our medical office building joint ventures for $4.3 million.

On July 27, 2009, we amended our leases with Hearthstone Senior Services, L.P. ("Hearthstone"). Hearthstone's only operations consist of the management of the 32 facilities under these leases. The lease terms were modified to (i) convert the annual Base Rent escalator to a fixed 3%, (ii) defer payment of the Supplemental Rent through December 31, 2011, (iii) tighten restrictions on distributions until such time as Hearthstone achieves and sustains defined rent coverage levels, (iv) provide for transfer of ownership of Hearthstone to us in the event of certain major events of default and (v) put in place certain bankruptcy protections and enhanced oversight rights for us.

SECOND QUARTER 2009 FINANCING TRANSACTIONS

On April 1, 2009, we retired $30.0 million of senior notes with an interest rate of 6.25% due in February 2013 for $25.4 million.

During the second quarter of 2009, we issued 1.8 million shares of our common stock through our controlled equity offering program at an average price of $27.14 per share, resulting in net proceeds of approximately $47.0 million.

From July 1, 2009 to August 5, 2009, we issued 2.1 million shares of our common stock through our controlled equity offering program at an average price of $27.80 per share, resulting in net proceeds of approximately $58.4 million.

2009 GUIDANCE

As a result of the common shares issued to date in 2009, we are decreasing by $0.01 per share the high end of our full-year 2009 recurring diluted FFO guidance from $2.26 per share to $2.25 per share. We are also decreasing by $0.01 per share the high end of our full-year 2009 recurring diluted FAD guidance from $2.24 per share to $2.23 per share. Our revised guidance for recurring diluted FFO of $2.22 per share to $2.25 per share includes the retirement of $30.0 million of senior notes, the second quarter and post second quarter end issuances of common shares that are discussed above and excludes any acquisitions, investments, impairments or additional capital transactions that could occur for the remainder of 2009. Current guidance reflects the recent amendment of the Hearthstone leases and does not include any Supplemental Rent previously or prospectively deferred. Beginning in 2009, certain costs associated with acquisitions which were previously capitalized are now required to be expensed. While our guidance does not assume any acquisitions for the remainder of 2009, we would incur certain costs that would be expensed for any acquisitions we may make and those costs could be material.

CONFERENCE CALL INFORMATION

We have scheduled a conference call and webcast on Thursday, August 6, 2009 at 8:30 a.m. Pacific time (11:30 a.m. Eastern time) to discuss these results. The conference call is accessible by dialing 866-713-8566 and referencing conference ID number 76511885 or by logging on to our website at http://www.nhp-reit.com. The international dial-in number is 617-597-5325. The earnings release and any additional financial information that may be discussed on the conference call will also be available at the same location on our website. A digitized replay of the conference call will be available from 11:30 a.m. Pacific time (2:30 p.m. Eastern time) that day until 9:00 p.m. Pacific time (Midnight Eastern time) on September 6, 2009. Callers can access the replay by dialing 888-286-8010 or 617-801-6888 and entering conference ID number 32754392. Webcast replays will also be available on our website for at least 12 months following the conference call. Our supplemental information package for the quarter and six months ended June 30, 2009 is available on our website, free of charge, at http://www.nhp-reit.com by selecting "Investor Relations" followed by "Financial Information" and is included in our Current Report on Form 8-K filed August 5, 2009 with the SEC also containing this release. Shareholders may receive free of charge a complete set of our audited financial statements upon request.

ABOUT NATIONWIDE HEALTH PROPERTIES, INC.

Nationwide Health Properties, Inc. is a real estate investment trust (REIT) that invests primarily in healthcare real estate in the United States. As of June 30, 2009, the Company's portfolio of properties, including mortgage loans and properties owned by unconsolidated joint ventures, totaled 579 properties among the following segments: 279 senior housing facilities, 200 skilled nursing facilities, 82 medical office buildings, 11 continuing care retirement communities and 7 specialty hospitals. For more information on Nationwide Health Properties, Inc., visit our website at http://www.nhp-reit.com.

FORWARD LOOKING STATEMENTS

Certain information contained in this release includes forward-looking statements. Forward-looking statements include statements regarding our expectations, beliefs, intentions, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are not statements of historical facts. These statements may be identified, without limitation, by the use of forward-looking terminology such as "may," "will," "anticipates," "expects," "believes," "intends," "should" or comparable terms or the negative thereof. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those described in the statements. Risks and uncertainties associated with our business include (without limitation) the following: deterioration in the operating results or financial condition, including bankruptcies, of our tenants; non-payment or late payment of rent, interest or loan principal amounts by our tenants; our reliance on two tenants for a significant percentage of our revenue; occupancy levels at certain facilities; our level of indebtedness; changes in the ratings of our debt securities; maintaining compliance with our debt covenants; access to the capital markets and the cost and availability of capital; government regulations, including changes in the reimbursement levels under the Medicare and Medicaid programs; the general distress of the healthcare industry; increasing competition in our business sector; the effect of economic and market conditions and changes in interest rates; the amount and yield of any additional investments; risks associated with acquisitions, including our ability to identify and complete favorable transactions, delays or failures in obtaining third party consents or approvals, the failure to achieve perceived benefits, unexpected costs or liabilities and potential litigation; the ability of our tenants to pay contractual rent and/or interest escalations in future periods; the ability of our tenants to obtain and maintain adequate liability and other insurance; our ability to attract new tenants for certain facilities; our ability to sell certain facilities for their book value; our ability to retain key personnel; potential liability under environmental laws; the possibility that we could be required to repurchase some of our senior notes; the rights and influence of holders of our outstanding preferred stock; changes in or inadvertent violations of tax laws and regulations and other factors that can affect our status as a real estate investment trust; and other factors discussed from time to time in our news releases, public statements and/or filings with the Securities and Exchange Commission, especially the "Risk Factors" sections of our Annual and Quarterly Reports on Forms 10-K and 10-Q. Forward-looking information is provided by us pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 and should be evaluated in the context of these factors. We disclaim any intent or obligation to update these forward-looking statements.

*** Financial Tables to Follow ***

                        NATIONWIDE HEALTH PROPERTIES, INC.
                          CONSOLIDATED INCOME STATEMENTS
                       (In thousands, except per share data)
                                    (Unaudited)

                                         Three Months Ended   Six Months Ended
                                              June 30,            June 30,
                                          ----------------    ----------------
                                           2009      2008      2009      2008
                                           ----      ----      ----      ----
    Revenue:
      Triple-net lease rent             $73,650   $70,583  $147,913  $139,656
      Medical office building
       operating rent                    17,003    15,939    33,656    26,870
                                         ------    ------    ------    ------
                                         90,653    86,522   181,569   166,526
      Interest and other income           6,658     6,549    12,993    11,816
                                          -----     -----    ------    ------
                                         97,311    93,071   194,562   178,342
    Expenses:
      Interest and amortization of
       deferred financing costs          23,247    25,507    47,319    50,246
      Depreciation and amortization      30,892    28,788    61,919    56,070
      General and administrative          6,973     6,407    13,904    12,904
      Medical office building
       operating expenses                 7,128     6,699    13,962    11,562
                                          -----     -----    ------    ------
                                         68,240    67,401   137,104   130,782
                                         ------    ------   -------   -------
    Operating income                     29,071    25,670    57,458    47,560
      Income from unconsolidated joint
       ventures                           1,174       848     2,187     1,901
      Gain on debt extinguishment, net    4,564         -     4,564         -
                                          -----       ---     -----       ---
    Income from continuing operations    34,809    26,518    64,209    49,461
    Discontinued operations
      Gains on sale of facilities, net        -   140,226    21,152   151,092
      Income from discontinued
       operations                            17     1,223        98     4,861
                                            ---     -----       ---     -----
                                             17   141,449    21,250   155,953
                                            ---   -------    ------   -------
    Net income                           34,826   167,967    85,459   205,414
      Net (income) loss attributable
       to noncontrolling interests          (75)       46      (102)       55
                                            ---       ---      ----       ---
    Net income attributable to NHP       34,751   168,013    85,357   205,469
      Preferred stock dividends          (1,452)   (2,062)   (2,904)   (4,125)
                                         ------    ------    ------    ------
    Income available to NHP common
     stockholders                       $33,299  $165,951   $82,453  $201,344
                                        =======  ========   =======  ========

    Basic earnings per share (EPS):
      Income from continuing
       operations attributable to NHP
       common stockholders                $0.32     $0.25     $0.59     $0.46
      Discontinued operations
       attributable to NHP common
       stockholders                           -      1.47      0.21      1.63
                                            ---      ----      ----      ----
      Net income attributable to NHP
       common stockholders                $0.32     $1.72     $0.80     $2.09
                                          =====     =====     =====     =====

    Diluted EPS:
      Income from continuing
       operations attributable to NHP
       common stockholders                $0.31     $0.25     $0.58     $0.46
      Discontinued operations
       attributable to NHP common
       stockholders                           -      1.44      0.20      1.61
                                            ---      ----      ----      ----
      Net income attributable to NHP
       common stockholders                $0.31     $1.69     $0.78     $2.07
                                          =====     =====     =====     =====

    Weighted average shares
     outstanding for EPS:
      Basic                             103,089    96,351   102,724    95,813
                                        =======    ======   =======    ======
      Diluted                           105,182    98,013   104,797    96,823
                                        =======    ======   =======    ======



                        NATIONWIDE HEALTH PROPERTIES, INC.
           RECONCILIATIONS OF NET INCOME TO NON-GAAP FINANCIAL MEASURES
                      (In thousands, except per share data)
                                   (Unaudited)

                   Reconciliation of Net Income to Diluted FFO

                                       Three Months Ended    Six Months Ended
                                             June 30,            June 30,
                                         ----------------    ----------------
                                          2009      2008      2009      2008
                                          ----      ----      ----      ----

    Net income                         $34,826  $167,967   $85,459  $205,414
      Preferred stock dividends         (1,452)   (2,062)   (2,904)   (4,125)
      Net (income) loss attributable
       to noncontrolling interests         (75)       46      (102)       55
      Real estate related
       depreciation and amortization    30,567    28,888    61,374    57,476
      Depreciation in income from
       unconsolidated joint ventures     1,312     1,131     2,618     2,246
      Gains on sale of facilities, net       -  (140,226)  (21,152) (151,092)
                                           ---  --------   -------  --------
    FFO available to NHP common
     stockholders                       65,178    55,744   125,293   109,974
      Series B preferred dividend
       add-back                          1,452     2,062     2,904     4,125
                                         -----     -----     -----     -----
    Diluted FFO                         66,630    57,806   128,197   114,099
      Gain on extinguishment of
       debt, net                        (4,564)        -    (4,564)        -
                                        ------       ---    ------       ---
    Recurring diluted FFO              $62,066   $57,806  $123,633  $114,099
                                       =======   =======  ========  ========

    Weighted average shares
     outstanding for diluted FFO:
      Diluted weighted average shares
       outstanding (1)                 105,241    98,114   104,848    96,949
      Series B preferred stock
       conversion add-back if not
       already converted                 3,368     4,736     3,363     4,732
                                         -----     -----     -----     -----
      Fully diluted weighted average
       shares outstanding              108,609   102,850   108,211   101,681
                                       =======   =======   =======   =======

    Diluted FFO per share                $0.61     $0.56     $1.18     $1.12
                                         =====     =====     =====     =====
    Recurring diluted FFO per share      $0.57     $0.56     $1.14     $1.12
                                         =====     =====     =====     =====

    Dividends declared per common
     share                               $0.44     $0.44     $0.88     $0.88
                                         =====     =====     =====     =====

    Recurring diluted FFO payout ratio      77%       79%       77%       79%
                                           ===       ===       ===       ===
    Recurring diluted FFO coverage        1.30      1.27      1.30      1.27
                                          ====      ====      ====      ====

    (1) Diluted weighted average shares outstanding includes the effect of
        all participating and non-participating share-based payment awards
        which for us consists of stock options and other share-based payment
        awards if the effect is dilutive.  The dilutive effect of all
        share-based payment awards is calculated using the treasury stock
        method.  Additionally, our redeemable OP units are included as if
        converted to common stock on a one-for-one basis.



                        NATIONWIDE HEALTH PROPERTIES, INC.
           RECONCILIATIONS OF NET INCOME TO NON-GAAP FINANCIAL MEASURES
                       (In thousands, except per share data)
                                    (Unaudited)

                    Reconciliation of Net Income to Diluted FAD

                                        Three Months Ended    Six Months Ended
                                              June 30,            June 30,
                                          ----------------    ----------------
                                           2009      2008      2009      2008
                                           ----      ----      ----      ----

    Net income                          $34,826  $167,967   $85,459  $205,414
      Preferred stock dividends          (1,452)   (2,062)   (2,904)   (4,125)
      Net (income) loss attributable
       to noncontrolling interests          (75)       46      (102)       55
      Real estate related depreciation
       and amortization                  30,567    28,888    61,374    57,476
      Gains on sale of facilities, net        -  (140,226)  (21,152) (151,092)
      Straight-lined rent                (1,599)   (2,759)   (3,188)   (5,597)
      Amortization of intangible
       assets and liabilities               (48)     (150)     (271)     (274)
      Non-cash stock-based
       compensation expense               1,837     1,440     3,410     2,771
      Deferred finance cost
       amortization                         756       777     1,570     1,524
      Lease commissions and tenant and
       capital improvements              (1,343)   (1,047)   (2,069)   (1,894)
      Unconsolidated joint ventures:
        Real estate related
         depreciation and amortization    1,312     1,131     2,618     2,246
        Straight-lined rent                 (12)        -       (23)      (10)
        Deferred finance cost
         amortization                        21        23        42        42
                                            ---       ---       ---       ---
    FAD available to NHP common
     stockholders                        64,790    54,028   124,764   106,536
      Series B preferred dividends        1,452     2,062     2,904     4,125
                                          -----     -----     -----     -----
    Diluted FAD                          66,242    56,090   127,668   110,661
      Gain on extinguishment of
       debt, net                         (4,564)        -    (4,564)        -
                                         ------       ---    ------       ---
    Recurring diluted FAD               $61,678   $56,090  $123,104  $110,661
                                        =======   =======  ========  ========

    Weighted average shares
     outstanding for diluted FAD:
      Diluted weighted average shares
       outstanding (1)                  105,241    98,114   104,848    96,949
      Series B preferred stock add-
       back if not already converted      3,368     4,736     3,363     4,732
                                          -----     -----     -----     -----
      Fully diluted weighted average
       shares outstanding               108,609   102,850   108,211   101,681
                                        =======   =======   =======   =======

    Diluted FAD per share                 $0.61     $0.55     $1.18     $1.09
                                          =====     =====     =====     =====
    Recurring diluted FAD per share       $0.57     $0.55     $1.14     $1.09
                                          =====     =====     =====     =====

    Dividends declared per common share   $0.44     $0.44     $0.88     $0.88
                                          =====     =====     =====     =====

    Diluted FAD payout ratio                 77%       80%       77%       81%
                                            ===       ===       ===       ===
    Diluted FAD coverage                   1.30      1.25      1.30      1.24
                                           ====      ====      ====      ====

    (1) Diluted weighted average shares outstanding includes the effect of
        all participating and non-participating share-based payment awards
        which for us consists of stock options and other share-based payment
        awards if the effect is dilutive.  The dilutive effect of all
        share-based payment awards is calculated using the treasury stock
        method.  Additionally, our redeemable OP units are included as if
        converted to common stock on a one-for-one basis.



                 NATIONWIDE HEALTH PROPERTIES, INC.
     RECONCILIATION OF NET INCOME TO NON-GAAP FINANCIAL MEASURES
                (In thousands, except per share data)

                            2009 Guidance
      Reconciliation of Net Income to Recurring Diluted FFO and
                            FAD Per Share

                                                 Year Ended
                                              December 31, 2009
                                             ------------------
                                                  Guidance
                                                  --------
                                                Low      High
                                                ---      ----

    Net income                               $156,213  $159,767
      Preferred stock dividends                (5,810)   (5,810)
      Real estate related depreciation and
       amortization                           119,517   119,517
      Depreciation in income from
       unconsolidated joint ventures            5,155     5,155
      Minority interest - NHP/PMB                 165       165
      Gains on sale of facilities, net        (31,499)  (31,499)
                                              -------   -------
    FFO available to common stockholders      243,741   247,295
      Series B preferred dividends              5,810     5,810
                                                -----     -----
    Diluted FFO                               249,551   253,105
      Gain on extinguishment of debt, net      (4,564)   (4,564)
                                               ------    ------
    Recurring diluted FFO                     244,987   248,541
      Straight-lined rent                      (6,272)   (6,272)
      Amortization of intangible assets and
       liabilities                               (535)     (535)
      Non-cash stock-based compensation
       expense                                  7,092     7,092
      Deferred finance cost amortization        3,120     3,120
      Lease commissions and tenant and
       capital improvements                    (5,608)   (5,608)
      Unconsolidated Joint Ventures:
        Straight-lined rent                       (27)      (27)
        Deferred finance cost amortization         84        84
                                                  ---       ---
    Recurring diluted FAD                    $242,841  $246,395
                                             ========  ========

    Diluted FFO per share                       $2.26     $2.29
                                                =====     =====
    Recurring diluted FFO per share             $2.22     $2.25
                                                =====     =====
    Recurring diluted FAD per share             $2.20     $2.23
                                                =====     =====

    Weighted average shares outstanding:
      Diluted weighted average shares
       outstanding                            105,354   105,354
      NHP/PMB OP units                          1,830     1,830
      Series B preferred stock conversion       3,375     3,375
                                                -----     -----
      Total                                   110,559   110,559
                                              =======   =======



                       NATIONWIDE HEALTH PROPERTIES, INC.
                          CONSOLIDATED BALANCE SHEETS
                                 (In thousands)

                                                    June 30,    December 31,
                                                      2009         2008
                                                      ----         ----
                                                  (Unaudited)
    Assets
      Investments in real estate:
        Land                                        $318,852      $320,394
        Buildings and improvements                 3,078,118     3,079,819
                                                   ---------     ---------
                                                   3,396,970     3,400,213
        Less accumulated depreciation               (538,705)     (490,112)
                                                    --------      --------
                                                   2,858,265     2,910,101
        Mortgage loans receivable, net               110,902       112,399
        Mortgage loan receivable from related
         party                                        47,500        47,500
        Investments in unconsolidated joint
         ventures                                     50,765        54,299
                                                      ------        ------
          Net real estate related investments      3,067,432     3,124,299
      Cash and cash equivalents                      121,729        82,250
      Receivables, net                                 7,858         6,066
      Asset held for sale                                  -         4,542
      Intangible assets                              103,666       109,434
      Other assets                                   131,531       131,534
                                                     -------       -------
          Total assets                            $3,432,216    $3,458,125
                                                  ==========    ==========

    Liabilities and Equity
      Unsecured senior credit facility                    $-            $-
      Senior notes                                   994,233     1,056,233
      Notes and bonds payable                        438,612       435,199
      Accounts payable and accrued liabilities       130,339       144,566
                                                     -------       -------
        Total liabilities                          1,563,184     1,635,998

      Redeemable OP unitholder interests              55,070        56,778

    Equity:
      NHP stockholders' equity
        Series B convertible preferred stock          74,918        74,918
        Common stock                                  10,449        10,228
        Capital in excess of par value             1,845,817     1,786,193
        Cumulative net income                      1,642,246     1,556,889
        Accumulated other comprehensive (loss)
         income                                         (608)        1,846
        Cumulative dividends                      (1,763,129)   (1,669,407)
                                                  ----------    ----------
        Total NHP stockholders' equity             1,809,693     1,760,667
      Noncontrolling interests                         4,269         4,682
                                                       -----         -----
        Total equity                               1,813,962     1,765,349
                                                   ---------     ---------
          Total liabilities and equity            $3,432,216    $3,458,125
                                                  ==========    ==========

    Contact:
    Abdo H. Khoury
    Chief Financial and Portfolio Officer
    (949) 718-4400


'/>"/>
SOURCE Nationwide Health Properties, Inc.
Copyright©2009 PR Newswire.
All rights reserved


Related medicine news :

1. AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009
2. MedCath Corporation Reports Third Quarter Earnings
3. Almost Family Reports Second Quarter 2009 Results
4. The Advisory Board Company Reports Fiscal Year 2010 First Quarter Results
5. Clarient Reports Second Quarter Revenue Up 40 Percent
6. Cambrex Reports Second Quarter 2009 Results
7. Valeant Pharmaceuticals Reports Second Quarter Financial Results
8. Landauer, Inc. Reports Fiscal 2009 Third Quarter Results
9. Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009
10. Consumer Reports Survey: HMOs Beat PPOs on Cost, Customer Support and Billing Services
11. Consumer Reports Launches Online Hospital Ratings for More Than 3,400 U.S. Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, ... journal articles published in Emergency Medicine Practice and Pediatric Emergency Medicine ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
Breaking Medicine Technology: